BIOMAT Database Logo BIOMAT Database Logo

Commentary on "Clinicopathological features of programmed cell death-ligand 1 expression in patients with oral squamous cell carcinoma". 2022

Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Oral surgery and Implantology Department, Universidad Rey Juan Carlos, Faculty of Health Sciences, University Clinic, Av. de Atenas, S/N, 28922 Alcorcón, Madrid, Spain.

UI MeSH Term Description Entries

Related Publications

Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Clinicopathological Features of Programmed Cell Death-ligand 1 Expression in Patients with Oral Squamous Cell Carcinoma.
January 2020, Open medicine (Warsaw, Poland),
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis.
June 2020, Archives of oral biology,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma.
September 2022, The International journal of biological markers,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis.
November 2020, Archives of oral biology,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
May 2016, Oncotarget,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
The pattern and clinicopathological correlates of programmed death-ligand 1 expression in cutaneous squamous cell carcinoma.
May 2017, The British journal of dermatology,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
[Development of programmed death receptor-1 and programmed death receptor-1 ligand in oral squamous cell carcinoma].
August 2020, Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype.
October 2016, Pathology,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.
February 2024, Oncology letters,
Juan Francisco Peña-Cardelles, and José Ernesto Moro-Rodríguez, and José Luís Cebrián-Carretero, and José Juan Pozo-Kreilinger
Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma.
November 2021, Oncology letters,
Copied contents to your clipboard!